|
FR2754177B1
(fr)
*
|
1996-10-07 |
1999-08-06 |
Sanofi Sa |
Microspheres pharmaceutiques d'acide valproique pour administration orale
|
|
DE19809719A1
(de)
|
1998-03-06 |
1999-09-09 |
Roehm Gmbh |
Wäßrige Dispersion geeignet zur Herstellung von Überzugs- und Bindemitteln für feste orale Arzneiformen
|
|
DE19845358A1
(de)
*
|
1998-10-02 |
2000-04-06 |
Roehm Gmbh |
Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe
|
|
JP5420126B2
(ja)
*
|
1999-02-04 |
2014-02-19 |
アボット・ラボラトリーズ |
ｐＨ非依存延長放出性医薬組成物
|
|
EP1064938A1
(en)
*
|
1999-06-28 |
2001-01-03 |
Sanofi-Synthelabo |
Pharmaceutical dosage forms for controlled release producing at least a timed pulse
|
|
PT1616561E
(pt)
*
|
1999-12-28 |
2008-07-09 |
Ajinomoto Kk |
Preparação antidiabética para administração oral
|
|
HRP20020709A2
(en)
*
|
2000-02-29 |
2004-12-31 |
Teva Pharma |
Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
|
|
FR2826274B1
(fr)
*
|
2001-06-21 |
2003-09-26 |
Aventis Pharma Sa |
Formulation pharmaceutique au gout masque et son procede de preparation
|
|
PT1469833T
(pt)
|
2002-02-01 |
2021-07-13 |
Bend Res Inc |
Método para produzir dispersões de fármaco amorfo sólido seco por pulverização homogéneas utilizando aparelho de secagem por pulverização modificado
|
|
NZ534746A
(en)
*
|
2002-03-12 |
2006-06-30 |
Bristol Myers Squibb Co |
Palatable oral suspension and method
|
|
US6930119B2
(en)
*
|
2002-07-17 |
2005-08-16 |
Reliant Pharmaceuticals, Inc. |
Liquid pharmaceutical composition
|
|
CA2499550C
(en)
*
|
2002-09-20 |
2013-10-15 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
|
US20040091544A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Ruff Michael D. |
Coated dibasic calcium phosphate
|
|
US20040170686A1
(en)
*
|
2003-01-31 |
2004-09-02 |
Fredrickson Jennifer K. |
Suspension vehicle for coated drug particles
|
|
US20040186180A1
(en)
|
2003-03-21 |
2004-09-23 |
Gelotte Cathy K. |
Non-steroidal anti-inflammatory drug dosing regimen
|
|
US20040191326A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Reo Joseph P. |
Taste-masking vehicle for coated oxazolidinone particles
|
|
US7520489B2
(en)
*
|
2003-06-17 |
2009-04-21 |
Filtertek Inc. |
Fluid handling device and method of making same
|
|
CL2004001884A1
(es)
*
|
2003-08-04 |
2005-06-03 |
Pfizer Prod Inc |
Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros.
|
|
US20050137262A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Hu Patrick C. |
Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
|
|
EP1763337A2
(en)
*
|
2003-12-31 |
2007-03-21 |
Actavis Group HF |
Immediate, controlled and sustained release formulations of galanthamine
|
|
EP1776089A2
(en)
*
|
2003-12-31 |
2007-04-25 |
Actavis Group hf |
Donepezil formulations
|
|
US20050163837A1
(en)
*
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Rosiglitazone formulations
|
|
US20050163843A1
(en)
*
|
2003-12-31 |
2005-07-28 |
Garth Boehm |
Alprazolam formulations
|
|
EP1703898A2
(en)
*
|
2003-12-31 |
2006-09-27 |
Alpharma, Inc. |
Ziprasidone formulations
|
|
CA2552064A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Actavis Group Hf |
Atomoxetine formulations
|
|
US20050142193A1
(en)
*
|
2003-12-31 |
2005-06-30 |
Lijuan Tang |
Galantamine formulations
|
|
WO2005065663A1
(en)
*
|
2003-12-31 |
2005-07-21 |
Alpharma, Inc. |
Rosiglitazone and metformin formulations
|
|
CA2577852A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Pfizer Products Inc. |
Pharmaceutical dosage forms comprising a low-solubility drug and a polymer
|
|
GB2419094A
(en)
*
|
2004-10-12 |
2006-04-19 |
Sandoz Ag |
Pharmaceutical composition of unpleasnt tasing active substances
|
|
US7378109B2
(en)
*
|
2004-12-23 |
2008-05-27 |
Council Of Scientific And Industrial Research |
Pharmaceutical composition for improving palatability of drugs and process for preparation thereof
|
|
US20060205682A1
(en)
*
|
2005-02-25 |
2006-09-14 |
Roberts Richard H |
Antibiotic and combinations of antibiotic and symptomatic relief agent formulations
|
|
BRPI0611272A2
(pt)
*
|
2005-05-03 |
2011-11-16 |
Mutual Pharmaceutical Co |
formulações de quinina
|
|
CN1883456B
(zh)
*
|
2005-06-20 |
2010-12-15 |
常州市第四制药厂有限公司 |
掩味药物颗粒及其制备方法和用途
|
|
JP2007031407A
(ja)
*
|
2005-07-29 |
2007-02-08 |
Shin Etsu Chem Co Ltd |
低置換度セルロースエーテル含有コーティング用組成物及び不快な味が隠蔽されたフィルムコーティング製剤
|
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
|
US9101160B2
(en)
|
2005-11-23 |
2015-08-11 |
The Coca-Cola Company |
Condiments with high-potency sweetener
|
|
WO2007109057A2
(en)
*
|
2006-03-16 |
2007-09-27 |
Novartis Ag |
Solid dosage form containing a taste masked active agent
|
|
JP4892264B2
(ja)
*
|
2006-03-30 |
2012-03-07 |
高田製薬株式会社 |
リスペリドン水性液剤
|
|
EP2719378B1
(en)
|
2006-06-19 |
2016-08-31 |
Alpharma Pharmaceuticals LLC |
Pharmaceutical compositions
|
|
US7569612B1
(en)
|
2006-08-21 |
2009-08-04 |
Mutual Pharmaceutical Company, Inc. |
Methods of use of fenofibric acid
|
|
JP2010506833A
(ja)
*
|
2006-10-11 |
2010-03-04 |
アルファーマ，インコーポレイテッド |
医薬組成物
|
|
US8017168B2
(en)
|
2006-11-02 |
2011-09-13 |
The Coca-Cola Company |
High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
|
|
WO2008065502A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Pfizer Products Inc. |
Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
|
|
KR20090094319A
(ko)
*
|
2006-12-26 |
2009-09-04 |
시오노기 앤드 컴파니, 리미티드 |
리스페리돈을 함유하는 구강내붕괴 정제 및 고미억제 제제
|
|
JP4941977B2
(ja)
*
|
2007-04-11 |
2012-05-30 |
大蔵製薬株式会社 |
ベンズイソキサゾール誘導体の経口ゼリー状医薬組成物
|
|
US20100119612A1
(en)
*
|
2007-04-17 |
2010-05-13 |
Bend Research, Inc |
Nanoparticles comprising non-crystalline drug
|
|
US20100080852A1
(en)
*
|
2007-05-03 |
2010-04-01 |
Ronald Arthur Beyerinck |
Phamaceutical composition comprising nanoparticles and casein
|
|
US8309129B2
(en)
*
|
2007-05-03 |
2012-11-13 |
Bend Research, Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
WO2008135855A2
(en)
*
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
|
|
US8974827B2
(en)
*
|
2007-06-04 |
2015-03-10 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
US20100215747A1
(en)
*
|
2007-07-13 |
2010-08-26 |
Corey Jay Bloom |
Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
|
|
EP2240162A4
(en)
*
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
|
|
US9724362B2
(en)
*
|
2007-12-06 |
2017-08-08 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
|
CA2709992A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Abuse resistant pharmaceutical compositions of opiod agonists
|
|
WO2010110018A1
(ja)
|
2009-03-27 |
2010-09-30 |
東レ株式会社 |
被覆固形製剤
|
|
US20110150986A1
(en)
*
|
2009-12-18 |
2011-06-23 |
Kristin Arnold |
Quinine formulations, method of making, and metho of use thereof
|
|
SG183993A1
(en)
*
|
2010-03-09 |
2012-10-30 |
Alkermes Pharma Ireland Ltd |
Alcohol resistant enteric pharmaceutical compositions
|
|
WO2013156163A1
(en)
|
2012-04-19 |
2013-10-24 |
Glatt Ag |
Taste-masked pharmaceutical compositions containing diclofenac
|
|
PL2919903T3
(pl)
|
2012-11-14 |
2020-12-14 |
W.R. Grace & Co. - Conn. |
Kompozycje zawierające materiał biologicznie aktywny i nieuporządkowany tlenek nieorganiczny
|
|
WO2017057884A1
(ko)
*
|
2015-09-30 |
2017-04-06 |
(주)아모레퍼시픽 |
자가회복 가능한 코어-쉘 캡슐
|
|
US9463183B1
(en)
|
2015-10-30 |
2016-10-11 |
Silvergate Pharmaceuticals, Inc. |
Lisinopril formulations
|
|
WO2020011938A1
(en)
|
2018-07-11 |
2020-01-16 |
Medizinische Universität Wien |
Glucocorticoids for the topical treatment of autoimmune gastritis
|
|
CN113181133A
(zh)
*
|
2021-04-25 |
2021-07-30 |
海南通用三洋药业有限公司 |
一种罗红霉素胶囊的制备方法
|
|
CN116687843A
(zh)
*
|
2022-12-16 |
2023-09-05 |
中国人民解放军军事科学院军事医学研究院 |
一种高稳定性的布瓦西坦溶液及其制备方法和其应用
|